Exploring Flavonoids as Regulators of MMP ‐2 and MMP ‐9 in Cancer Pathogenesis
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70145 ↗At a glance
Journal article in Chemical Biology & Drug Design, 2025. Written by Ha Vy Thi Vo and 4 co-authors. Institution: Department of Chemistry Education, Kongju National University, Gongju, Chungcheongnam-do, Republic of Korea. Major MEDLINE topics: Matrix Metalloproteinase 2, Matrix Metalloproteinase 9, Flavonoids, Matrix Metalloproteinase Inhibitors. Cited 5 times so far (Crossref); 88 references. Funded by: National Research Foundation of Korea.
Abstract (original language)
Last few decades, extensive research efforts have been dedicated to uncovering novel cancer treatments. Among the most vital targets in this pursuit are matrix metalloproteinases (MMPs), enzymes integral to the progression and spread of cancer. Their role in tumor development and metastasis positions MMPs as key players in cancer pathogenesis, offering promising avenues for therapeutic intervention. Specifically, MMP‐2 and MMP‐9 have emerged as promising targets in cancer treatment based on their critical roles in cell invasion, angiogenesis, immune evasion, and metastasis. Studies indicate the potential of plant‐derived natural products as anticancer agents through the regulation of MMP activity. Among various phytochemicals, flavonoids are reported to exhibit inhibitory activities against MMPs and antioxidant properties that present them as candidates for anticancer molecules. In this study, the potential of flavonoids as anticancer agents was explored by investigating the effects of flavonoids on (i) cancer cell viability and migration, (ii) enzymatic activity and cellular expression of MMP‐2/9, and (iii) the MAPK signaling pathway. Docking simulation data regarding the interactions between MMP‐2/9 and selected flavonoids provide an in‐depth look at the potential mechanisms through which these molecules suppress the enzymatic activities of MMPs. Select flavonoids exhibited notable efficacy in suppressing cell proliferation and migration in A549 cells, which may be a consequence of their ability to attenuate MMP activity and expression through the suppression of the MAPK signaling pathway. These observations demonstrate the prospect of flavonoids as a naturally occurring molecular framework for the development of novel anticancer therapeutics.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemistry Education, Kongju National University, Gongju, Chungcheongnam-do, Republic of Korea.
- Department of Biological Science, Kongju National University, Gongju, Chungcheongnam-do, Republic of Korea.
- Department of Chemistry, Kongju National University, Gongju, Chungcheongnam-do, Republic of Korea.
ORCID profiles: Song Ja Kim, Namdoo Kim, Hyuck Jin Lee
Funding
- National Research Foundation of Korea
Cite
APA
Vo, H. V. T., Patton, G. N., Kim, S. J., Kim, N., & Lee, H. J. (2025). Exploring Flavonoids as Regulators of MMP ‐2 and MMP ‐9 in Cancer Pathogenesis. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70145
Vancouver
Vo HVT, Patton GN, Kim SJ, Kim N, Lee HJ. Exploring Flavonoids as Regulators of MMP ‐2 and MMP ‐9 in Cancer Pathogenesis. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70145
BibTeX
@article{Vo2025,
author = {Vo, Ha Vy Thi and Patton, Geewoo Nam and Kim, Song Ja and Kim, Namdoo and Lee, Hyuck Jin},
title = {Exploring Flavonoids as Regulators of MMP ‐2 and MMP ‐9 in Cancer Pathogenesis},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70145}
}
EUVIMED